HEXB
Beta-hexosaminidase subunit beta
Also known as: HEXB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07686
- Gene
- HEXB
- Ensembl
- ENSG00000049860
- Chromosome
- 5
- Canonical length
- 556 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
Canonical amino-acid sequenceUniProt
556 residues, UniProt reviewed canonical sequence.
>P07686|HEXB
1 MELCGLGLPR PPMLLALLLA TLLAAMLALL TQVALVVQVA EAARAPSVSA KPGPALWPLP
61 LLVKMTPNLL HLAPENFYIS HSPNSTAGPS CTLLEEAFRR YHGYIFGFYK WHHEPAEFQA
121 KTQVQQLLVS ITLQSECDAF PNISSDESYT LLVKEPVAVL KANRVWGALR GLETFSQLVY
181 QDSYGTFTIN ESTIIDSPRF SHRGILIDTS RHYLPVKIIL KTLDAMAFNK FNVLHWHIVD
241 DQSFPYQSIT FPELSNKGSY SLSHVYTPND VRMVIEYARL RGIRVLPEFD TPGHTLSWGK
301 GQKDLLTPCY SRQNKLDSFG PINPTLNTTY SFLTTFFKEI SEVFPDQFIH LGGDEVEFKC
361 WESNPKIQDF MRQKGFGTDF KKLESFYIQK VLDIIATINK GSIVWQEVFD DKAKLAPGTI
421 VEVWKDSAYP EELSRVTASG FPVILSAPWY LDLISYGQDW RKYYKVEPLD FGGTQKQKQL
481 FIGGEACLWG EYVDATNLTP RLWPRASAVG ERLWSSKDVR DMDDAYDRLT RHRCRMVERG
541 IAAQPLYAGY CNHENMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HEXB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 303 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 303 nTPM
- placenta: 300 nTPM
- liver: 128 nTPM
- salivary gland: 120 nTPM
- rectum: 110 nTPM
- blood vessel: 109 nTPM
Single-cell type
- syncytiotrophoblasts: 625 nCPM
- cytotrophoblasts: 597 nCPM
- migrating cytotrophoblasts: 367 nCPM
- hofbauer cells: 297 nCPM
- extravillous trophoblasts: 289 nCPM
- epididymal principal cells: 236 nCPM
Immune cell
- classical monocyte: 344 nTPM
- myeloid DC: 311 nTPM
- total PBMC: 269 nTPM
- intermediate monocyte: 130 nTPM
- neutrophil: 126 nTPM
- eosinophil: 99 nTPM
Brain region
- choroid plexus: 58 nTPM
- white matter: 39 nTPM
- thalamus: 35 nTPM
- hypothalamus: 29 nTPM
- basal ganglia: 27 nTPM
- pons: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HEXB.
Disease | AllUniProt
Conditions HEXB is implicated in, by any mechanism.
- GM2-gangliosidosis 2 (GM2G2) MIM:268800
Disease | GeneticClinVar
226 pathogenic / likely-pathogenic of 943 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Sandhoff disease
- Sandhoff disease, infantile form
- Sandhoff disease, adult form
- See cases
- Sandhoff disease, juvenile form
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- astrocyte cell migration
- chondroitin sulfate proteoglycan catabolic process
- dermatan sulfate proteoglycan catabolic process
- ganglioside catabolic process
- glycosaminoglycan metabolic process
- hyaluronan catabolic process
- intracellular calcium ion homeostasis
- lipid storage
- locomotory behavior
- lysosome organization
- myelination
- N-acetylglucosamine metabolic process
- N-glycan processing
- neuromuscular process controlling balance
- neuron cellular homeostasis
- oligosaccharide catabolic process
- oogenesis
- penetration of zona pellucida
- phospholipid biosynthetic process
- positive regulation of transcription by RNA polymerase II
- regulation of cell shape
- sensory perception of sound
- single fertilization
- skeletal system development
- male courtship behavior
Molecular functions
- acetylglucosaminyltransferase activity
- beta-N-acetylhexosaminidase activity
- carbohydrate binding
- identical protein binding
- protein-containing complex binding
- beta-N-acetylglucosaminidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HEXB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HEXB as an antibody target. Whether an autoantibody or antibody against HEXB could matter depends on whether native HEXB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HEXB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HEXB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...